You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Genes, erbb2

Showing 1 - 25 of 8,671
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Worldwide (BDTX-189)

Terminated
  • Solid Tumor
  • Scottsdale, Arizona
  • +37 more
Oct 13, 2022

Osimertinib for NSCLC With Uncommon EGFR Mutations

Enrolling by invitation
  • Carcinoma, Non-Small-Cell Lung
  • Genes, erbB-1
  • Ramat Gan, Israel
    Sheba Medical Centre
Jun 14, 2022

Key Genes in Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Carcinoma
  • None of intervention
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Type2 Diabetes, Coronary Artery Disease Trial in Miami (Liraglutide Pen Injector [Victoza], matching liraglutide- pre-filled

Recruiting
  • Type2 Diabetes
  • Coronary Artery Disease
  • Liraglutide Pen Injector [Victoza]
  • matching liraglutide-placebo pre-filled pens
  • Miami, Florida
    University of Miami
Nov 4, 2022

Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

Completed
  • Recurrent Miscarriages
    • London, United Kingdom
      St. Mary's Hospital
    Aug 4, 2022

    Tumors, Breast Trial in France, Ireland, United States (lapatinib, docetaxel, trastuzumab)

    Terminated
    • Neoplasms, Breast
    • lapatinib, docetaxel, trastuzumab
    • Nashville, Tennessee
    • +4 more
    Jun 30, 2022

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +5 more
    • Trastuzumab
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 31, 2023

    Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

    Recruiting
    • Metastatic Salivary Gland Carcinoma
    • +4 more
    • New York, New York
      Memorial Sloane Kettering Cancer Center
    Jan 11, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Necitumumab
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jan 5, 2023

    HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

    Completed
    Has Results
    • HER2 Positive Breast Carcinoma
    • +6 more
    • Palo Alto, California
      Stanford University, School of Medicine
    Sep 22, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Copper Cu 64-DOTA-Trastuzumab
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    HER2-low in Unresectable and/or Metastatic Breast Cancer

    Not yet recruiting
    • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
      • (no location specified)
      Nov 6, 2023

      Genes Contributing to Hereditary Ovarian Cancer in Women and

      Completed
      • Ovarian Cancer
        • Seattle, Washington
          University of Washington
        Feb 2, 2022

        Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • +3 more
        • Guanzhou, China
          SunYat-senU
        May 5, 2023

        T2Resistance - Detection of Resistance Related Genes

        Recruiting
        • Resistance Bacterial
        • T2Resistance Panel
        • New Orleans, Louisiana
          Ochsner Medical Center
        Mar 18, 2022

        Genes in Pancreatic Cancer for Better Treatment Selection

        Active, not recruiting
        • Carcinoma, Pancreatic Ductal
        • Molecular Profiling
        • Kingston, Ontario, Canada
        • +3 more
        Jan 25, 2023

        HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

        Completed
        • Epithelial Ovarian Cancer
        • +6 more
        • Evaluation of homologous recombination deficiency score
        • Beijing, Beijing, China
          Lei Li
        Mar 26, 2022

        Genetics, Metabolism, Type 2 Diabetes Trial in Boston (Mixed Meal Tolerance Test, Metformin)

        Active, not recruiting
        • Genetics
        • +2 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Apr 4, 2022